You are using an older browser version. Please use a supported version for the best MSN experience.

Eisai Set to Rise on Hopes for Alzheimer’s Drug

Oct.22 -- Eisai Co. shares are expected to rise after the Japanese drugmaker and partner Biogen Inc. said they will ask U.S. regulators to approve their nearly abandoned experimental treatment for Alzheimer’s. Rachel Chang reports on "Bloomberg Daybreak: Asia."

Recent Videos

Featured Partners

image beaconimage beaconimage beacon